Remove Big Data Remove Drugs Remove Genomics
article thumbnail

The future of AI drug discovery & development in immunology and GPCR research

pharmaphorum

Alphabet subsidiary and precision health company Verily recently announced a breakthrough in its AI drug discovery GPCR research collaboration with Sosei Heptares. The companies hope that in the year to come those data targets will be entered for validation, hit generation, and lead selection. What, then, is the solution?

article thumbnail

Recognizing the Real People Behind the Big Data and Artificial Intelligence in Clinical Research

ACRP blog

If you hadn’t already noticed, the clinical research enterprise has well and truly entered the era of “big data,” artificial intelligence (AI), and machine learning. Edited by Gary Cramer The post Recognizing the Real People Behind the Big Data and Artificial Intelligence in Clinical Research appeared first on ACRP.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digitalising drug discovery

pharmaphorum

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . on Big data: astronomical or genomical? ,

article thumbnail

Integrated evidence generation 2.0: A strategy for every stakeholder

pharmaphorum

The advent of biologic therapies in the 1970s along with the decoding of the human genome in 2003 heralded an explosion in pharmaceutical innovation.

article thumbnail

Takeda, Daiichi-backed wearable study planned in Japan

pharmaphorum

The results generated in the study will be combined with data from Tohoku’s Medical Megabank Project (TMM), a wide-ranging national project that is tracking the health of the Japanese population, originally set up in response to the 2011 earthquake and tsunami.

article thumbnail

5th Microbiome Movement – Drug Development Summit Europe 2021

pharmaphorum

The post 5th Microbiome Movement – Drug Development Summit Europe 2021 appeared first on. Despite this progress, the vast potential to develop effective treatments that target the human microbiome is still limited by the complex challenges in developing them.

article thumbnail

From Wearables to AI: Digital Health Tools Are Driving Cancer Care

XTalks

RELATED: OncoHealth Expands Its Iris Platform for Digital Cancer Care Big Data and AI in Oncology Big data analytics is opening new avenues in cancer research. Large datasets from clinical trials, patient records and genomic studies can be analyzed to identify patterns and correlations previously unattainable.